Oza, AM;    Matulonis, UA;    Alvarez Secord, A;    Nemunaitis, J;    Roman, LD;    Blagden, SP;    Banerjee, S;                                                                                     ... Matei, D; + view all <#>        Oza, AM;  Matulonis, UA;  Alvarez Secord, A;  Nemunaitis, J;  Roman, LD;  Blagden, SP;  Banerjee, S;  McGuire, WP;  Ghamande, S;  Birrer, MJ;  Fleming, GF;  Markham, MJ;  Hirte, HW;  Provencher, DM;  Basu, B;  Kristeleit, R;  Armstrong, DK;  Schwartz, B;  Braly, P;  Hall, GD;  Nephew, KP;  Jueliger, S;  Oganesian, A;  Naim, S;  Hao, Y;  Keer, H;  Azab, M;  Matei, D;   - view fewer <#>    (2020)    A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.                   Clinical Cancer Research , 26  (5)   pp. 1009-1016.    10.1158/1078-0432.CCR-19-1638 <https://doi.org/10.1158/1078-0432.CCR-19-1638>.       Green open access